New Directions Technology Consulting, LLC v. Abbott Laboratories Inc.
1:25-cv-00506
Overview
Parties
Defendant
Bigfoot Biomedical, Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Abbott Laboratories Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
New Directions Technology Consulting, LLC Operating Company
Represented By
4 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
222 Delaware Avenue, Suite 900
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 7,752,085 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,871,393 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2008001455 | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 7,810,403 | European Counterpart (EP) | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 2,040,604 A4 | European Counterpart (EP) | View Official Patent → |
| π PCT International (WIPO) | WO 2008008451 A2 | PCT World Application | View Official Patent → |
| πΊπΈ United States | US 8,212,658 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,149,111 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012029332 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7871393
Injection device with reporting ability
|
Filed: 2006-07-13
Issued: 2011-01-18
|
Active (0.7 yrs remaining)
+373d PTA
Expires: 2027-07-21
|
|
|
US8044778
Injection device and case with reporting ability
|
Filed: 2009-01-12
Issued: 2011-10-25
|
Active (1.5 yrs remaining)
Expires: 2028-06-04
|
|
|
US8149111
Central facility that communicates with portable container via mobile device
|
Filed: 2011-07-27
Issued: 2012-04-03
|
Active (4.7 yrs remaining)
Expires: 2031-07-27
|
|
|
US8212658
Product container for use with device capable of long-range and short-range communications
|
Filed: 2011-07-27
Issued: 2012-07-03
|
Active (4.7 yrs remaining)
Expires: 2031-07-27
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+373 days) / Cellect Scrutiny β Over 373 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
18
Dispositive
8
Granted
1
Denied
1
Pending / Review
14
Motions by Category
Key Dispositive Motions & Rulings